Nulease Medical Solutions LLC

Nulease Medical Solutions LLC was paid $23.53M by Medicaid between Jan 2018 and Nov 2024, across 86 billing codes. Its largest line is G0481, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed — 14% of everything it billed.

Compared with peers

Next to other Addiction Medicine (Psychiatry & Neurology) Physician providers in Kentucky

Rank by total paid#1 of 5

Median peer was paid$1.26M

This provider vs. median19×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	34,166	$580K
2019	121,957	$3.15M
2020	164,319	$5.75M
2021	133,510	$4.96M
2022	95,239	$3.97M
2023	51,631	$2.92M
2024incomplete	37,858	$2.20M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	14%	28,376	18,067	$3.25M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	8.0%	40,898	20,591	$1.89M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	7.8%	41,209	28,864	$1.85M
T1007	Alcohol and/or substance abuse services, treatment plan development and/or modification	7.7%	32,026	18,254	$1.81M
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	7.1%	11,791	7,932	$1.67M
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	6.5%	16,935	13,929	$1.52M
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	6.1%	8,246	5,395	$1.43M
H0001	Alcohol and/or drug assessment	5.8%	23,308	16,956	$1.38M
H2027	Psychoeducational service, per 15 minutes	3.4%	20,399	12,576	$790K
99215	Doctor's office visit, returning patient (complex)Prolong outpt/office vis	3.1%	11,589	6,267	$732K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	2.7%	12,263	8,360	$642K
H0025	Behavioral health prevention education service (delivery of services with target population to affect knowledge, attitude and/or behavior)	2.5%	46,931	21,522	$591K

74 more codes

80305		2.4%	56,838	$560K
H0031	Mental health assessment, by non-physician	1.9%	9,123	$448K
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	1.9%	15,164	$444K
90832	Psychotherapy session, about 30 minutes	1.8%	16,420	$434K
90792	Psychiatric diagnostic evaluation with medical services	1.7%	9,055	$392K
90853	Group psychotherapy (other than of a multiple-family group)	1.6%	36,422	$388K
H0049	Alcohol and/or drug screening	1.1%	16,320	$261K
99408		1.1%	23,947	$257K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	1.0%	3,566	$242K
H2011	Crisis intervention service, per 15 minutes	<1%	15,029	$228K
90785		<1%	37,599	$212K
H0032	Mental health service plan development by non-physician	<1%	3,126	$170K
96156		<1%	5,712	$142K
H0002	Behavioral health screening to determine eligibility for admission to treatment program	<1%	2,625	$133K
90791	Psychiatric diagnostic evaluation	<1%	3,057	$130K
T2023	Targeted case management; per month	<1%	366	$127K
99205	Prolong outpt/office vis	<1%	1,572	$118K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	8,567	$112K
80306		<1%	8,217	$102K
81025		<1%	14,233	$101K
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	<1%	2,071	$94K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	1,657	$85K
99354		<1%	1,703	$74K
H0038	Self-help/peer services, per 15 minutes	<1%	7,216	$72K
96151		<1%	7,364	$64K
87631		<1%	947	$52K
H2015	Community support for mental illness or disability, per 15 minutes	<1%	1,491	$51K
99204	Doctor's office visit, new patient (more involved)	<1%	588	$48K
87563		<1%	1,670	$45K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	1,930	$43K
99401		<1%	2,386	$39K
97151		<1%	3,781	$39K
93000		<1%	2,116	$32K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	2,039	$28K
99203	Doctor's office visit, new patient (routine)	<1%	453	$27K
99406		<1%	4,516	$25K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	1,175	$23K
99407		<1%	2,305	$21K
90839		<1%	338	$20K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	738	$13K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	700	$13K
86769		<1%	588	$10K
96150		<1%	945	$7K
0012A		<1%	228	$7K
0011A		<1%	160	$5K
90834	Psychotherapy session, about 45 minutes	<1%	93	$5K
86318		<1%	505	$4K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	111	$4K
36415	Collection of venous blood by venipuncture	<1%	2,158	$4K
0031A		<1%	125	$4K
86632		<1%	314	$3K
86631		<1%	313	$3K
90837	Psychotherapy session, about an hour	<1%	98	$2K
99386		<1%	16	$2K
0034A		<1%	43	$1K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	13	$1K
0013A		<1%	33	$960.00
99484		<1%	48	$891.38
90887		<1%	55	$869.04
96127		<1%	527	$823.20
90875		<1%	1,402	$729.31
G0396	Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes	<1%	33	$127.21
86635		<1%	17	$104.61
86602		<1%	17	$92.82
G2087	Office-based treatment for opioid use disorder, including care coordination, individual therapy and group therapy and counseling; at least 60 minutes in a subsequent calendar month	<1%	25	$81.36
94760		<1%	36	$51.31
90863		<1%	806	$16.88
888888		0%	274	$0.00
99072		0%	1,054	$0.00
T2024	Service assessment/plan of care development, waiver	0%	69	$0.00
97156		0%	39	$0.00
H2019	Therapeutic behavioral services, billed per 15 minutes	0%	112	$0.00
99000		0%	191	$0.00
97154		0%	119	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCALES, SHANNON (OWNER)